Powder: -20°C for 3 years | In solvent: -80°C for 1 year
ERCC1-XPF-IN-2 is active in nucleotide excision repair, cisplatin enhancement and γH2AX assays. ERCC1-XPF-IN-2 is a potent inhibitor of ERCC1-XPF endonuclease with an IC 50 value of 0.6 μM [1].
Pack Size | Availability | Price/USD | Quantity |
---|---|---|---|
2 mg | In stock | $ 34.00 | |
5 mg | In stock | $ 55.00 | |
10 mg | In stock | $ 97.00 | |
25 mg | In stock | $ 197.00 | |
50 mg | In stock | $ 328.00 | |
100 mg | In stock | $ 497.00 | |
200 mg | In stock | $ 693.00 | |
500 mg | In stock | $ 1,080.00 |
Description | ERCC1-XPF-IN-2 is active in nucleotide excision repair, cisplatin enhancement and γH2AX assays. ERCC1-XPF-IN-2 is a potent inhibitor of ERCC1-XPF endonuclease with an IC 50 value of 0.6 μM [1]. |
In vitro | ERCC1-XPF-IN-2 (compound 13) (0-100 µM) shows DNase I and FEN-1 activity with IC50s of >100, >100 µM, respectively. ERCC1-XPF-IN-2 shows binding kinetics with Kd of ~30 µM. ERCC1-XPF-IN-2 has nontoxic to Hep-G2 cells at 10 µM and relatively short mouse and human microsomal half-lives with t1/2 of 23 min and 28 min for mouse and human, respectively. ERCC1-XPF-IN-2 (0-60 µM; 24 h) shows inhibition of nucleotide excision repair (NER) with an IC50 of 15.6 μM in A375 cells. ERCC1-XPF-IN-2 (0-60 µM) increases the cisplatin activity with nontoxic. ERCC1-XPF-IN-2 (10 µM; 6h) causes a delay in DNA repair by a right shift towards higher numbers of γH2AX foci per cell[1]. |
Molecular Weight | 326.17 |
Formula | C15H13Cl2NO3 |
CAS No. | 1808986-37-9 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
DMSO: 225.0 mg/mL (689.8 mM)
You can also refer to dose conversion for different animals. More
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
ERCC1-XPF-IN-2 1808986-37-9 Others inhibitor inhibit